Publications

  1. Dominantly Inherited Alzheimer Network, Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, McDade E, Ringman JM, Rossor M, Salloway S, Schofield PR, Holtzman DM, Morris JC, Bateman RJ. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain 2016 Oct; 139 (Pt 10):2766-2777 Epub 2016 Aug 12
    View PubMed
  2. Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleo A, Morenas-Rodriguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiol Aging 2016 Sep 2 Epub 2016 Sept 02
    View PubMed
  3. Singh Ospina N, Brito JP, Maraka S, Espinosa de Ycaza AE, Rodriguez-Gutierrez R, Gionfriddo MR, Castaneda-Guarderas A, Benkhadra K, Al Nofal A, Erwin P, Morris JC, Castro MR, Montori VM. Diagnostic accuracy of ultrasound-guided fine needle aspiration biopsy for thyroid malignancy: systematic review and meta-analysis. Endocrine 2016 Sep; 53 (3):651-61 Epub 2016 Apr 12
    View PubMed
  4. Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC 3rd, Stan MN. Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study. Thyroid 2016 Aug 22 [Epub ahead of print]
    View PubMed
  5. Espinosa AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC 3rd, Stan. Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study Thyroid.2016;().
  6. Espinosa AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC 3rd, Stan. Risk of Malignancy in Thyroid Nodules with Non-diagnostic Fine Needle Aspiration: A Retrospective Cohort Study Thyroid.2016;().
  7. Singh Ospina N, Maraka S, Espinosa De Ycaza AE, Ahn HS, Castro MR, Morris JC, Montori VM, Brito JP. Physical exam in asymptomatic people drivers the detection of thyroid nodules undergoing ultrasound guided fine needle aspiration biopsy. Endocrine 2016 Aug 10 [Epub ahead of print]
    View PubMed
  8. Brito JP, Ospina NM, Morris JC. Ramifications of New Terminology for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma. JAMA Oncol 2016 Aug 1; 2 (8):1097
    View PubMed
  9. Singh Ospina N, Maraka S, Espinosa De Ycaza A, Espinosa DeYcaza A, O'Keeffe D, Brito JP, Gionfriddo MR, Castro MR, Morris JC, Erwin P, Montori VM. Diagnostic accuracy of thyroid nodule growth to predict malignancy in thyroid nodules with benign cytology: systematic review and meta-analysis. Clin Endocrinol (Oxf) 2016 Jul; 85 (1):122-31 Epub 2016 Jan 25
    View PubMed
  10. Dominantly Inherited Alzheimer Network, Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Forster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C Jr, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network. Ann Neurol 2016 Jun; 79 (6):929-39 Epub 2016 Apr 27
    View PubMed
  11. Spitzweg C, Morris JC, Bible KC. New drugs for medullary thyroid cancer: new promises? Endocr Relat Cancer 2016 Jun; 23 (6):R287-97 Epub 2016 May 16
    View PubMed
  12. Singh Ospina N, Maraka S, Espinosa de Ycaza AE, Brito JP, Castro MR, Morris JC, Montori VM. Prognosis of patients with benign thyroid nodules: a population-based study. Endocrine 2016 May 3 Epub 2016 May 03
    View PubMed
  13. Brito JP, Singh-Ospina N, Gionfriddo MR, Maraka S, Espinosa De Ycaza A, Rodriguez-Gutierrez R, Morris JC, Montori VM, Tuttle RM. Restricting ultrasound thyroid fine needle aspiration biopsy by nodule size: which tumors are we missing? A population-based study. Endocrine 2016 Mar; 51 (3):499-505 Epub 2015 Aug 09
    View PubMed
  14. Cummings J, Aisen PS, DuBois B, Frolich L, Jack CR Jr, Jones RW, Morris JC, Raskin J, Dowsett SA, Scheltens P. Drug development in Alzheimer's disease: the path to 2025. Alzheimers Res Ther 2016; 8:39 Epub 2016 Sept 20
    View PubMed
  15. Singh Ospina N, Sebo TJ, Morris JC, Castro MR. The Value of Repeat Thyroid Fine-Needle Aspiration Biopsy in Patients with a Previously Benign Result: How Often Does It Alter Management? Thyroid 2015 Oct; 25 (10):1121-6 Epub 2015 Aug 17
    View PubMed
  16. Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012. Thyroid 2015 Sep; 25 (9):999-1007 Epub 2015 July 30
    View PubMed
  17. Morley JE, Morris JC, Berg-Weger M, Borson S, Carpenter BD, Del Campo N, Dubois B, Fargo K, Fitten LJ, Flaherty JH, Ganguli M, Grossberg GT, Malmstrom TK, Petersen RD, Rodriguez C, Saykin AJ, Scheltens P, Tangalos EG, Verghese J, Wilcock G, Winblad B, Woo J, Vellas B. Woo J, Vellas B. Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference. J Am Med Dir Assoc 2015 Sep 1; 16 (9):731-9
    View PubMed
  18. Dominantly Inherited Alzheimer Network, Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, Sperling R, Salloway S, Schofield PR, Masters CL, Martins RN, Rossor MN, Jucker M, Danek A, Forster S, Lane CA, Morris JC, Benzinger TL, Bateman RJ.ster S, Lane CA, Morris JC, Benzinger TL, Bateman RJ, Dominantly Inherited Alzheimer Network. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology 2015 Sep 1; 85 (9):790-8 Epub 2015 Aug 05
    View PubMed
  19. Alzheimer's Disease Neuroimaging Initiative, Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ. Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. Alzheimers Dement 2015 Jul; 11 (7):865-84
    View PubMed
  20. Alzheimer's Disease Neuroimaging Initiative, Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Green RC, Harvey D, Jack CR, Jagust W, Luthman J, Morris JC, Petersen RC, Saykin AJ, Shaw L, Shen L, Schwarz A, Toga AW, Trojanowski JQ. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement 2015 Jun; 11 (6):e1-120
    View PubMed
  21. Davies L, Morris LGT, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyriod cancer. Endocr Pract. 2015 Jun; 21(6):686-96.
    View PubMed
  22. Dominantly Inherited Alzheimer Network, Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A, Muller-Sarnowski F, Clifford DB, McDade EM, Brooks WS, Darby DG, Masters CL, Weston PS, Farlow MR, Graff-Radford NR, Salloway SP, Fagan AM, Oliver A, Bateman RJ. Inherited Alzheimer Network. Factors associated with the onset and persistence of post-lumbar puncture headache. JAMA Neurol 2015 Mar; 72 (3):325-32
    View PubMed
  23. Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI. RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI. At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement 2015 Jan; 11 (1):70-98 Epub 2014 July 09
    View PubMed
  24. McIver B, Castro MR, Morris JC, Bernet V, Smallridge R, Henry M, Kosok L, Reddi H. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2014 Nov; 99(11):4069-77. Epub 2014 Apr 29.
    View PubMed
  25. Alzheimer Disease Genetics Consortium, Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, et al. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol 2014 Nov; 71 (11):1394-404
    View PubMed
  26. Spitzweg C, Bible KC, Hofbauer LC, Morris JC. Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets. Lancet Diabetes Endocrinol 2014 Oct; 2 (10):830-42 Epub 2014 June 02
    View PubMed
  27. Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, Ourselin S, Schofield PR, Masters CL, Martins RN, Weiner MW, Thompson PM, Fox NC, Koeppe RA, Jack CR Jr, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BM. Koeppe RA, Jack CR Jr, Mathis CA, Oliver A, Blazey TM, Moulder K, Buckles V, Hornbeck R, Chhatwal J, Schultz AP, Goate AM, Fagan AM, Cairns NJ, Marcus DS, Morris JC, Ances BM. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. JAMA Neurol 2014 Sep; 71 (9):1111-22
    View PubMed
  28. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of thyroid: an unusual cause of thyrogobulin-positive radioactive iodine-negative whole-body scans. Thyroid. .2014;().
  29. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyrogobulin-positive radioactive iodine-negative whole-body scans. Thyroid. .2014;().
  30. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyrogobulin-positive radioactive iodine-negative whole-body scans. Thyroid.2014;().
  31. Fatourechi V, Morris JC 3rd, Sebo TJ. Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of they thyroid: an usual case of thyroglobulin-positive radioactive iodine-negative whole-body scans. Thyroid .2014;().
  32. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Karlin N, Sideras K, Morris JC 3rd, McIver B, Hay I, Fatourechi V, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Cher Goh B, Isham CR, Harris P, Erlichman C, for the Endocrine Malignancies Disease Oriented Group Mayo Clinic Cancer Center and the Mayo Phase 2 Consortium. Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, and the Mayo Phase 2 Consortium. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H. J Clin Endocrinol Metab. 2014 May; 99(5):1687-93. Epub 2014 Feb 25.
    View PubMed
  33. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Apr; 99(4):1253-63. Epub 2013 Nov 25.
    View PubMed
  34. Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ. 2014; 348:g3045. Epub 2014 Jun 16.
    View PubMed
  35. Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred. Thyroid. 2013 Dec; 23(12):1547-52. Epub 2013 Jul 25.
    View PubMed
  36. Trujillo MA, Oneal MJ, McDonough SJ, Morris JC. Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy. Gene Ther. 2013 May; 20(5):567-74. Epub 2012 Sep 13.
    View PubMed
  37. Alizad A, Urban MW, Morris JC, Reading CC, Kinnick RR, Greenleaf JF, Fatemi M. In vivo thyroid vibro-acoustography: a pilot study. BMC Med Imaging. 2013; 13:12. Epub 2013 Mar 27.
    View PubMed
  38. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013; 347:f4706. Epub 2013 Aug 27.
    View PubMed
  39. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A steep radioiodine dose response scalable to humans in sodium-iodide symporter (NIS)-mediated radiovirotherapy for prostate cancer. Cancer Gene Ther. 2012 Dec; 19(12):839-44. Epub 2012 Oct 05.
    View PubMed
  40. Oneal MJ, Trujillo MA, Davydova J, McDonough S, Yamamoto M, Morris JC. Characterization of infectivity-enhanced conditionally replicating adenovectors for prostate cancer radiovirotherapy. Hum Gene Ther. 2012 Sep; 23(9):951-9. Epub 2012 Aug 22.
    View PubMed
  41. Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Ther. 2012 Sep; 19(9):659-65. Epub 2012 Jul 13.
    View PubMed
  42. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. Am J Manag Care. 2012 May; 18(5):e162-7. Epub 2012 May 01.
    View PubMed
  43. Bible KC, Smallridge RC, Morris JC, Molina JR, Suman VJ, Copland JA, Rubin J, Menefee ME, Sideras K, Maples WJ, McIver B, Fatourechi V, Hay I, Foote RL, Garces YI, Kasperbauer JL, Thompson GB, Grant CS, Richards ML, Sebo T, Lloyd R, Eberhardt NL, Reddi HV, Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C., Casler JD, Karlin NJ, Westphal SA, Richardson RL, Buckner JC, Erlichman C. Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers. J Oncol Pract. 2012 May; 8(3 Suppl):e1s-5s.
    View PubMed
  44. Ahmed KA, Davis BJ, Wilson TM, Wiseman GA, Federspiel MJ, Morris JC. Progress in gene therapy for prostate cancer. Front Oncol. 2012; 2:172. Epub 2012 Nov 19.
    View PubMed
  45. Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, Morris JC. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011 Nov; 21(11):1191-8. Epub 2011 Oct 18.
    View PubMed
  46. Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW, Liu Z, Flavin R, O'Flatharta C, Foley MJ, Barrett HH, Murphy JM, Barry FP, O'Brien T, Kerin MJ. Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells. 2011 Jul; 29(7):1149-57.
    View PubMed
  47. Foote RL, Molina JR, Kasperbauer JL, Lloyd RV, McIver B, Morris JC, Grant CS, Thompson GB, Richards ML, Hay ID, Smallridge RC, Bible KC. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy. Thyroid. 2011 Jan; 21(1):25-30. Epub 2010 Dec 16.
    View PubMed
  48. Ryan J, Curran CE, Hennessy E, Newell J, Morris JC, Kerin MJ, Dwyer RM. The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. PLoS One. 2011; 6(1):e16023. Epub 2011 Jan 19.
    View PubMed
  49. Alzheimer's Disease Genetics Consortium, Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, Cantwell LB, Dombroski BA, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD. Bennett DA, Morris JC, Lunetta KL, Martin ER, Montine TJ, Goate AM, Blacker D, Tsuang DW, Beekly D, Cupples LA, Hakonarson H, Kukull W, Foroud TM, Haines J, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 2010 Dec; 67 (12):1473-84 Epub 2010 Aug 09
    View PubMed
  50. Trujillo MA, Oneal MJ, McDonough S, Qin R, Morris JC. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer. Gene Ther. 2010 Nov; 17(11):1325-32. Epub 2010 Apr 29.
    View PubMed
  51. Bible KC, Suman VJ, Molina JR, Smallridge RC, Maples WJ, Menefee ME, Rubin J, Sideras K, Morris JC 3rd, McIver B, Burton JK, Webster KP, Bieber C, Traynor AM, Flynn PJ, Goh BC, Tang H, Ivy SP, Erlichman C, Endocrine Malignancies Disease Oriented Group, Mayo Clinic Cancer Center, Mayo Phase 2 Consortium.yo Clinic Cancer Center, Mayo Phase 2 Consortium. Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study. Lancet Oncol. 2010 Oct; 11(10):962-72. Epub 2010 Sep 17
    View PubMed
  52. Spitzweg C, Morris JC. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 2010 Jun 30; 322(1-2):56-63. Epub 2010 Feb 12.
    View PubMed
  53. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, Shaw L, Saykin AJ, Morris JC, Cairns N, Beckett LA, Toga A, Green R, Walter S, Soares H, Snyder P, Siemers E, Potter W, Cole PE, Schmidt M, Alzheimer's Disease Neuroimaging Initiative. The Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimers Dement. 2010 May; 6(3):202-11.e7.
    View PubMed
  54. Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010 May; 6(3):239-46.
    View PubMed
  55. Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Mol Ther. 2009 Dec; 17(12):2041-8. Epub 2009 Sep 22.
    View PubMed
  56. Morris JC. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clin Endocrinol (Oxf). 2009 May; 70(5):671-3. Epub 2009 Feb 17.
    View PubMed
  57. Trujillo MA, Oneal MJ, Davydova J, Bergert E, Yamamoto M, Morris JC 3rd. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer. Breast Cancer Res. 2009; 11(4):R53. Epub 2009 Jul 27.
    View PubMed
  58. Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate. 2009 Jan 1; 69(1):82-91.
    View PubMed
  59. Willhauck MJ, Samani BR, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Meyer GJ, Knapp WH, Goke B, Morris JC, Spitzweg C. The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer. Eur J Nucl Med Mol Imaging. 2008 Jul; 35(7):1272-81. Epub 2008 Apr 11.
    View PubMed
  60. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, Sebo TJ, Morris JC 3rd. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008 May-Jun; 14(4):426-31.
    View PubMed
  61. Willhauck MJ, Sharif-Samani B, Senekowitsch-Schmidtke R, Wunderlich N, Goke B, Morris JC, Spitzweg C. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone. Breast Cancer Res Treat. 2008 May; 109(2):263-72. Epub 2007 Jul 18.
    View PubMed
  62. Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Goke B, Morris JC, Spitzweg C. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma. Gene Ther. 2008 Feb; 15(3):214-23. Epub 2007 Nov 8
    View PubMed
  63. Rao VP, Miyagi N, Ricci D, Carlson SK, Morris JC 3rd, Federspiel MJ, Bailey KR, Russell SJ, McGregor CG. Sodium iodide symporter (hNIS) permits molecular imaging of gene transduction in cardiac transplantation. Transplantation. 2007 Dec 27; 84(12):1662-6.
    View PubMed
  64. Willhauck MJ, Samani BRS, Gildehaus FJ, Wolf I, Senekowitsch-Schmidtke R, Stark HJ, Goke B, Morris JC, Spitzweg C. Application of (188)Rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression. Journal of Clinical Endocrinology & Metabolism. 2007 Nov; 92(11):4451-8.
    View PubMed
  65. Spitzweg C, Baker CH, Bergert ER, O'Connor MK, Morris JC. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression. Hum Gene Ther. 2007 Oct; 18(10):916-24.
    View PubMed
  66. Dingli D, Russell SJ, Morris JC. Reporting transgene expression using NIS. J Cell Biochem. 2007.
  67. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther. 2006 Jun; 17(6):661-8.
    View PubMed
  68. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice. Gene Ther. 2006 Jan; 13(1):60-6.
    View PubMed
  69. Unterholzner S, Willhauck MJ, Cengic N, Schutz M, Goke B, Morris JC, Spitzweg C. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab. 2006 Jan; 91(1):69-78. Epub 2005 Oct 18.
    View PubMed
  70. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol. 2006 Jan-Feb; 8(1):16-23.
    View PubMed
  71. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed
  72. Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochem Biophys Res Commun. 2005 Nov 11; 337(1):22-9.
    View PubMed
  73. Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer. Mol Ther. 2005 Nov; 12(5):835-41. Epub 2005 Jul 27.
    View PubMed
  74. Cengic N, Baker CH, Schutz M, Goke B, Morris JC, Spitzweg C. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression. J Clin Endocrinol Metab. 2005 Aug; 90(8):4457-64.
    View PubMed
  75. Dwyer RM, Bergert ER, O'Connor MK, Gendler SJ, Morris JC. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Clin Cancer Res. 2005 Feb 15; 11(4):1483-9.
    View PubMed
  76. Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Goke B, Morris JC, Spitzweg C. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther. 2005 Feb; 12(3):272-80.
    View PubMed
  77. Dingli D, Bergert ER, Bajzer Z, O'connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochem Biophys Res Commun. 2004 Dec 3; 325(1):157-66.
    View PubMed
  78. Baker CH, Morris JC. The sodium-iodide symporter. Current Drug Targets - Immune Endocrine & Metabolic Disorders. 2004 Sep; 4(3):167-74.
    View PubMed
  79. Guo J, Pichurin PN, Morris JC, Rapoport B, McLachlan SM. Naked deoxyribonucleic acid vaccination induces recognition of diverse thyroid peroxidase T cell epitopes. Endocrinology. 2004 Aug; 145(8):3671-8. Epub 2004 May 03.
    View PubMed
  80. Spitzweg C, Morris JC. Gene therapy for thyroid cancer: Current status and future prospects. Thyroid. 2004 Jun; 14(6):424-34.
    View PubMed
  81. Scholz IV, Cengic N, Goke B, Morris JC, Spitzweg C. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter. J Clin Endocrinol Metab. 2004 Mar; 89(3):1108-16.
    View PubMed
  82. Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 2004 Mar 1; 103(5):1641-6. Epub 2003 Nov 06.
    View PubMed
  83. Fatourechi V, Klee GG, Grebe SK, Bahn RS, Brennan MD, Hay ID, McIver B, Morris JC. Effects of reducing the upper limit of normal TSH values. JAMA: Journal of the American Medical Association. 2003 Dec 24; 290(24):3195-6.
    View PubMed
  84. Dingli D, Russell SJ, Morris JC 3rd. In vivo imaging and tumor therapy with the sodium iodide symporter. J Cell Biochem. 2003 Dec 15; 90(6):1079-86.
    View PubMed
  85. Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer. Cancer Res. 2003 Nov 15; 63(22):7840-4.
    View PubMed
  86. Spitzweg C, Scholz IV, Bergert ER, Tindall DJ, Young CYF, Goke B, Morris JC. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells. Endocrinology. 2003 Aug; 144(8):3423-32.
    View PubMed
  87. Dobert N, Hamscho N, Bergert ER, Oeschger S, Berner U, Goellner J, Menzel C, Morris JC, Grunwald F. Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression. Nuklearmedizin. 2003 Aug; 42(4):N42-4.
    View PubMed
  88. Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood. 2003 Jul 15; 102(2):489-96. Epub 2003 Mar 20.
    View PubMed
  89. Preissner CM, O'Kane DJ, Singh RJ, Morris JC, Grebe SKG. Phantoms in the assay tube: Heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab. 2003 Jul; 88(7):3069-74.
    View PubMed
  90. Schwarz-Lauer L, Pichurin PN, Chen CR, Nagayama Y, Paras C, Morris JC, Rapoport B, McLachlan SM. The cysteine-rich amino terminus of the thyrotropin receptor is the immunodominant linear antibody epitope in mice immunized using naked deoxyribonucleic acid or adenovirus vectors. Endocrinology. 2003 May; 144(5):1718-25.
    View PubMed
  91. Spitzweg C, Morris JC. The sodium iodide symporter: its pathophysiological and therapeutic implications [Review]. Clin Endocrinol (Oxf) 2002 Nov; 57(5):559-74.
    View PubMed
  92. Pichurin P, Schwarz-Lauer L, Braley-Mullen H, Paras C, Pichurina O, Morris JC, Rapoport B, McLachlan SM. Peptide scanning for thyrotropin receptor T-cell epitopes in mice vaccinated with naked DNA. Thyroid. 2002 Sep; 12(9):755-64.
    View PubMed
  93. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab. 2002 Sep; 87(9):4154-9.
    View PubMed
  94. Spitzweg C, Morris JC. Sodium Iodide Symporter (NIS) and thyroid. Hormone. 2002; 1:22-34.
  95. Morris JC. Surgical treatment of inflammatory disease of the thyroid. Endocr Pract. 2002; 8(4):313-4.
    View PubMed
  96. Castro MR, Bergert ER, Goellner JR, Hay ID, Morris JC. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab. 2001 Nov; 86(11):5627-32.
    View PubMed
  97. Harrington KJ, Spitzweg C, Bateman AR, Morris JC, Vile RG. Gene therapy for prostate cancer: current status and future prospects. J Urol. 2001 Oct; 166(4):1220-33.
    View PubMed
  98. Pinke LA, Dean DS, Bergert ER, Spitzweg C, Dutton CM, Morris JC. Cloning of the mouse sodium iodide symporter. Thyroid. 2001 Oct; 11(10):935-9.
    View PubMed
  99. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther. 2001 Oct; 8(20):1524-31.
    View PubMed
  100. Smallridge RC, Castro MR, Morris JC, Young PR, Reynolds JC, Merino MJ, Sarlis NJ. Renal metastases from thyroid papillary carcinoma: study of sodium iodide symporter expression. Thyroid. 2001 Aug; 11(8):795-804.
    View PubMed
  101. Spitzweg C, Harrington KJ, Pinke LA, Vile RG, Morris JC. Clinical review 132: The sodium iodide symporter and its potential role in cancer therapy. J Clin Endocrinol Metab. 2001 Jul; 86(7):3327-35.
    View PubMed
  102. Graves JW, Morris JC, Sheps SG. Martorell's hypertensive leg ulcer: case report and concise review of the literature. J Hum Hypertens. 2001 Apr; 15(4):279-83.
    View PubMed
  103. Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. Expression of the sodium iodide symporter in human kidney. Kidney Int. 2001 Mar; 59(3):1013-23.
    View PubMed
  104. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001 Feb; 76(2):161-8.
    View PubMed
  105. Mitchell AM, Manley SW, Morris JC, Powell KA, Bergert ER, Mortimer RH. Sodium iodide symporter (NIS) gene expression in human placenta. Placenta. 2001 Feb-Mar; 22(2-3):256-8.
    View PubMed
  106. Spitzweg C, Morris JC. Approaches to gene therapy with sodium/iodide symporter. Exp Clin Endocrinol Diabetes. 2001; 109(1):56-9.
    View PubMed
  107. Spitzweg C, Bergert ER, Morris JC. Sodium iodide symporter: Its biology, clinical relevance, and potential role in the pathophysiology of autoimmune thyroid disease. Current Opinion in Endocrinology & Diabetes. 2001; 8(5):259-265.
  108. Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 2000 Nov 15; 60(22):6526-30.
    View PubMed
  109. Spitzweg C, Morris JC. The immune response to the iodide transporter. Endocrinol Metab Clin North Am. 2000 Jun; 29(2):389-98, viii.
    View PubMed
  110. Spitzweg C, Heufelder AE, Morris JC. Thyroid iodine transport. Thyroid. 2000 Apr; 10(4):321-30.
    View PubMed
  111. Castro MR, Kocher D, Morris JC. An unusual case of inappropriate secretion of thyrotropin: neoplastic or nonneoplastic? Endocr Pract. 2000 Jan-Feb; 6(1):29-33.
    View PubMed
  112. Castro MR, Bergert ER, Beito TG, Roche PC, Ziesmer SC, Jhiang SM, Goellner JR, Morris JC. Monoclonal antibodies against the human sodium iodide symporter: utility for immunocytochemistry of thyroid cancer. J Endocrinol. 1999 Dec; 163(3):495-504.
    View PubMed
  113. Spitzweg C, Joba W, Schriever K, Goellner JR, Morris JC, Heufelder AE. Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J Clin Endocrinol Metab. 1999 Nov; 84(11):4178-84.
    View PubMed
  114. Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab. 1999 Sep; 84(9):3328-35.
    View PubMed
  115. Castro MR, Bergert ER, Beito TG, McIver B, Goellner JR, Morris JC. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. J Clin Endocrinol Metab. 1999 Aug; 84(8):2957-62.
    View PubMed
  116. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid. 1999 Aug; 9(8):821-30.
    View PubMed
  117. Spitzweg C, Zhang S, Bergert ER, Castro MR, McIver B, Heufelder AE, Tindall DJ, Young CY, Morris JC. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines. Cancer Res. 1999 May 1; 59(9):2136-41.
    View PubMed
  118. Morris JC. The clinical expression of thyrotropin receptor mutations. Endocrinologist. 1998 May; 8(3):195-201.
  119. McIver B, Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am. 1998 Mar; 27(1):73-89.
    View PubMed
  120. Raju R, Navaneetham D, Kellermann SA, Freeman SL, Morris JC, McCormick DJ, Conti-Fine BM. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans. J Autoimmun. 1997 Oct; 10(5):479-89.
    View PubMed
  121. Morris JC, Bergert ER, Bryant WP. Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium-iodide symporter peptides: evidence for the iodide transporter as an autoantigen. Thyroid. 1997 Aug; 7(4):527-34.
    View PubMed
  122. Campbell RK, Bergert ER, Wang Y, Morris JC, Moyle WR. Chimeric proteins can exceed the sum of their parts: implications for evolution and protein design. Nat Biotechnol. 1997 May; 15(5):439-43.
    View PubMed
  123. Fu AZ, Morris JC, Ford GC, Nair KS. Sequential purification of human apolipoprotein B-100, albumin, and fibrinogen by immunoaffinity chromatography for measurement of protein synthesis. Anal Biochem. 1997 May 1; 247(2):228-36.
    View PubMed
  124. Morris JC. Structure and function of the TSH receptor: its suitability as a target for radiotherapy. Thyroid. 1997 Apr; 7(2):253-8.
    View PubMed
  125. McDonald ML, Daly RC, Schaff HV, Mullany CJ, Miller FA, Morris JJ, Orszulak TA. Hemodynamic performance of small aortic valve bioprostheses: is there a difference? Ann Thorac Surg. 1997 Feb; 63(2):362-6.
    View PubMed
  126. Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Daly RC, Morris JJ. Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg. 1996 Nov; 62(5):1424-30.
    View PubMed
  127. Porrata LF, Morris JC 3rd. 63-year-old woman with fever and right flank pain. Mayo Clin Proc. 1996 Oct; 71(10):1011-4.
    View PubMed
  128. Dallas JS, Cunningham SJ, Patibandla SA, Seetharamaiah GS, Morris JC, Tahara K, Kohn LD, Prabhakar BS. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Endocrinology. 1996 Aug; 137(8):3329-39.
    View PubMed
  129. Gehlot A, Mullany CJ, Ilstrup D, Schaff HV, Orzulak TA, Morris JJ, Daly RC. Aortic valve replacement in patients aged eighty years and older: early and long-term results. J Thorac Cardiovasc Surg. 1996 May; 111(5):1026-36.
    View PubMed
  130. Robinson BL, Morita T, Fujita K, Chow M, Schaff HV, Morris JJ. Bypass conduit vessel wall biology substantially influences downstream myocardial contractile response to injury from ischemia and reperfusion. J Thorac Cardiovasc Surg. 1996 Jan; 111(1):62-73.
    View PubMed
  131. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davies TF. Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology. 1995 Oct; 136(10):4415-23.
    View PubMed
  132. Kellermann SA, McCormick DJ, Freeman SL, Morris JC, Conti-Fine BM. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls. J Autoimmun. 1995 Oct; 8(5):685-98.
    View PubMed
  133. Sheehan MT, Morbeck DE, Bergert ER, McCormick DJ, Milius RP, Morris JC. Receptor-specific activity of heteromeric thyrotropin (TSH) analogs: development of synthetic TSH antagonists. Pept Res. 1995 Sep-Oct; 8(5):264-71.
    View PubMed
  134. Seetharamaiah GS, Wagle NM, Morris JC, Prabhakar BS. Generation and characterization of monoclonal antibodies to the human thyrotropin (TSH) receptor: antibodies can bind to discrete conformational or linear epitopes and block TSH binding. Endocrinology. 1995 Jul; 136(7):2817-24.
    View PubMed
  135. Nagy EV, Morris JC, Burch HB, Bhatia S, Salata K, Burman KD. Thyrotropin receptor T cell epitopes in autoimmune thyroid disease. Clinical Immunology & Immunopathology. 1995 May; 75(2):117-24.
    View PubMed
  136. Levine JA, Morris JC. The use of a football helmet to secure a nasogastric tube. Nutrition. 1995 May-Jun; 11(3):285.
    View PubMed
  137. Bryant WP, Bergert ER, Morris JC. Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides. Autoimmunity. 1995; 22(2):69-79.
    View PubMed
  138. Wagle NM, Dallas JS, Morris JC, Prabhakar BS. Thyrotropin receptor specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the IgG1 subclass. 6 1995 Endocrinology 13; 136:3461-9.
  139. Bryant WP, Bergert ER, Morris JC. Delineation of amino acid residues with hTSHr 256-275 that participate in hormone binding. J Biol Chem. 1994 Dec 9; 269:30935-8.
    View PubMed
  140. Oda RP, Madden BJ, Morris JC, Spelsberg TC, Landers JP. Multiple-buffer-additive strategies for enhanced capillary electrophoretic separation of peptides. J Chromatogr A. 1994 Sep 30; 680(1):341-51.
    View PubMed
  141. Dallas JS, Desai RK, Cunningham SJ, Morris JC, Seetharamaiah GS, Wagle N, Goldblum RM, Prabhakar BS. Thyrotropin (TSH) interacts with multiple discrete regions of the TSH receptor: polyclonal rabbit antibodies to one or more of these regions can inhibit TSH binding and function. Endocrinology. 1994 Mar; 134(3):1437-45.
    View PubMed
  142. Morris JC, Gibson JL, Haas EJ, Bergert ER, Dallas JS, Prabhakar BS. Identification of epitopes and affinity purification of thyroid stimulating auto-antibodies using synthetic human TSH receptor peptides. Autoimmunity. 1994; 17(4):287-99.
    View PubMed
  143. Morris JC, Bergert ER, McCormick DJ. Structure-function studies of the human thyrotropin receptor. Inhibition of binding of labeled thyrotropin (TSH) by synthetic human TSH receptor peptides. J Biol Chem. 1993 May 25; 268(15):10900-5.
    View PubMed
  144. Leinung MC, Bergert ER, McCormick DJ, Morris JC. Synthetic analogs of the carboxyl-terminus of beta-thyrotropin: the importance of basic amino acids in receptor binding activity. Biochemistry. 1992 Oct 20; 31(41):10094-8.
    View PubMed
  145. Nagy EV, Burch HB, Mahoney K, Lukes YG, Morris JC 3rd, Burman KD. Graves' IgG recognizes linear epitopes in the human thyrotropin receptor. Biochem Biophys Res Commun. 1992 Oct 15; 188(1):28-33.
    View PubMed
  146. Freeman SL, McCormick DJ, Ryan RJ, Morris JC. Inhibition of TSH bio-activity by synthetic beta TSH peptides. Endocr Res. 1992; 18(1):1-17.
    View PubMed
  147. Leinung MC, Reed DK, McCormick DJ, Ryan RJ, Morris JC. Further characterization of the receptor-binding region of the thyroid-stimulating hormone alpha subunit: a comprehensive synthetic peptide study of the alpha-subunit 26-46 sequence. Proc Natl Acad Sci U S A. 1991 Nov 1; 88(21):9707-11.
    View PubMed
  148. Cole LA, Kardana A, Andrade-Gordon P, Gawinowicz MA, Morris JC, Bergert ER, O'Connor J, Birken S. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Endocrinology. 1991 Sep; 129(3):1559-67.
    View PubMed
  149. Charlesworth MC, Bergert ER, Morris JC, McCormick DJ, Ryan RJ. The antigenic structure of the human glycoprotein hormone alpha-subunit: III. Solution- and solid-phase mapping using synthetic peptides. Endocrinology. 1991 Jun; 128(6):2907-15.
    View PubMed
  150. Morris JC, McCormick DJ, Ryan RJ. Inhibition of thyrotropin binding to receptor by synthetic human thyrotropin beta peptides. J Biol Chem. 1990 Feb 5; 265(4):1881-4.
    View PubMed
  151. Morris JC 3rd, Jiang NS, Hay ID, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab. 1988 Oct; 67(4):707-12.
    View PubMed
  152. Morris JC 3rd, Ranganathan G, Hay ID, Nelson RE, Jiang NS. The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology. 1988 Sep; 123(3):1385-94.
    View PubMed
  153. Morris JC 3rd, Jiang NS, Charlesworth MC, McCormick DJ, Ryan RJ. The effects of synthetic alpha-subunit peptides on thyrotropin interaction with its receptor. Endocrinology. 1988 Jul; 123(1):456-62.
    View PubMed
  154. Morris JC 3rd, Hay ID, Nelson RE, Jiang NS. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc. 1988 Jul; 63(7):707-17.
    View PubMed